Guarana is a plant-based energy booster that functions much like caffeine
Contact your GP urgently if you experience severe pain, signs of infection (increasing redness, warmth, discharge), or any concerning symptoms following injection
Your body has a repair crew to fix this, but they run on NAD+
In the same week that Pfizer decided to discontinue the development of danuglipron, an oral, small-molecule GLP-1 receptor agonist aimed at chronic weight management Lilly report a successful Phase 3 trial with Orforglipron, lowering A1C and body weight BREAKING: Lillys oral GLP-1, orforglipron, hits its primary endpoint in the Phase 3 ACHIEVE-1 trial for type 2 diabetes
4 Retatrutide isnt approved by the MHRA, and the realistic UK approval window is late 2027 to mid 2028, with NHS access from 2029 at the earliest